Found in Translation: New Directions in Drug Discovery at UW–Madison

Learn about new opportunities for moving solutions from the lab to the patient.

9am: Allan Brasier, Senior Associate Dan of the School of Medicine and Public Health and Executive Director of the Institute for Clinical and Translational Research (ICTR)

9:30am: Jon Young,  Head of WARF Therapeutics – a new initiative to advance pharmaceuticals closer to patients

10:30am: Networking & coffee break

11am: Panel of campus experts on panel with deep pharma development experience:

• Jennifer Golden: Assistant professor in the School of Pharmacy and associate director of the Medicinal Chemistry Center. Golden’s lab develops novel synthetic methodologies for designing small molecule therapeutics.
• Doug McNeel: Professor in the School of Medicine and Public Health and scientific founder and chief medical officer of Madison Vaccines Inc. MVI is a clinical stage biopharma company developing gene-based immunotherapies for prostate cancer.
• Luigi Puglielli: Professor in the School of Medicine and Public Health. Dr. Puglielli’s research focuses broadly on molecular mechanisms of neurodevelopment and neurodegeneration.

Register to secure your spot.